Related Experiment Videos
Papillary necrosis associated with rifampicin therapy
Australian and New Zealand Journal of Medicine
|February 1, 1987
Summary
Rifampicin therapy for tuberculosis can cause progressive kidney failure, even after treatment stops. Unique kidney pathology, including glomerulosclerosis and papillary necrosis, was observed.
Area of Science:
- Nephrology
- Infectious Diseases
- Pathology
Background:
- Renal tuberculosis is a serious infection requiring long-term antibiotic treatment.
- Rifampicin is a key component of multidrug regimens for tuberculosis.
- Drug-induced kidney injury is a recognized complication of various medications.
Observation:
- A patient receiving 13 months of rifampicin for renal tuberculosis developed worsening kidney function.
- Renal function decline persisted even after rifampicin was discontinued.
- Kidney biopsy revealed glomerulosclerosis, granulomatous interstitial nephritis, and papillary necrosis, without active tuberculosis.
Findings:
- Rifampicin-induced nephrotoxicity can lead to progressive and irreversible renal damage.
- The observed pathology (glomerulosclerosis, interstitial nephritis, papillary necrosis) is distinct from typical tuberculous kidney disease.
- This case highlights a rare but severe adverse effect of rifampicin therapy.
Implications:
- Clinicians should consider rifampicin-induced nephrotoxicity in patients with unexplained renal failure during or after tuberculosis treatment.
- Close monitoring of renal function is crucial for patients on long-term rifampicin.
- Further research into the mechanisms of rifampicin nephrotoxicity and diagnostic markers is warranted.